Showing results (1341-1350 of 2,739) with videos related to
Sort By:
Pageof 274
Pharmacogenomics|February 2, 2024
Update on HLA-B*15:02 allele associated with adverse drug reactionsXueting Zhu, Guanghua Luo, Lu ZhengPharmacogenomics|January 8, 2024
Association between CYP3A4, CYP3A5 and ABCB1 genotype and tacrolimus treatment outcomes among allogeneic HSCT patientsTeresa T Ho, Janelle B Perkins, Rebecca Gonzalez, et al.Pharmacogenomics|March 21, 2024
Implementation of whole-exome sequencing for pharmacogenomics profiling and exploring its potential clinical utilitiesDanyi Wang, Jayaprakasam Bolleddula, Anna Coenen-Stass, et al.Pharmacogenomics|September 30, 2024
A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid levelFarah Aida A Zairol Azwan, Yi Ying Teo, Nor Asyikin Mohd Tahir, et al.Pharmacogenomics|October 23, 2023
Retrospective pharmacogenetic study in a cohort of pediatric tuberous sclerosis complex patients using everolimusJulia Concha, Estela Sangüesa, Jose Luis Peña, et al.Pharmacogenomics|October 17, 2023
Towards more accurate pharmacogenomic variant effect predictionsYoomi Park, Volker LauschkePharmacogenomics|July 12, 2023
Warfarin pharmacogenetics in a black Zimbabwean cohort: an observational prospective studyMarie Madeleine M Hidjo, Zedias Chikwambi, Gift Ngwende, et al.Pharmacogenomics|July 20, 2023
UGT1A1 genotype-guided dosing of irinotecan: time to prioritize patient safetySofía Lj Peeters, Maarten J Deenen, Anna Mj Thijs, et al.Pharmacogenomics|July 17, 2023
Implication of KDM6A in bladder cancerMarianne Matar, Gilles Prince, Ibrahim Hamati, et al.Pharmacogenomics|July 17, 2023
PMAT variant rs3889348 is associated with metformin-induced gastrointestinal among Chinese Type 2 diabetes patientsZiqing Liu, Xiao Jia, Peng Wu, et al.Pageof 274